Paragon 28, an orthopedic medical device company focused exclusively on the foot and ankle, entered into a credit facility with MidCap Financial that provides access to up to $70 million in total credit.
“We are very pleased with this new credit facility and our relationship with MidCap, providing Paragon 28 access to flexible and cost-effective growth capital, which will further enable the company to invest in strategic growth initiatives to improve foot and ankle patient outcomes,” Albert DaCosta, co-founder and CEO of Paragon 28, said.
